Pfizer said it still expects adjusted 2025 profit of $2.80 a share to $3 a share, while analysts expect full-year earnings of $2.94 a share. Pfizer projected 2025 revenue of $61 billion to $64 billion ...

Match Group is finding common ground with its activist investors. The online-dating company said it's entered into an information-sharing agreement with Anson Funds Management. The agreement comes a ...

Spotify Technology's stock dropped sharply in premarket trade on Tuesday after missing on earnings and guiding for more "noise" to come. Spotify stock (SPOT) tumbled 5% in premarket trade. The stock ...

Shares of Royal Caribbean Group were climbing toward a sixth straight gain on Tuesday, after the cruise operator beat first-quarter profit expectations and boosted its full-year outlook, as it took in ...

Rheinmetall, the German defense and auto company whose stock has doubled this year, saw its shares rally again on Tuesday after blowing away analyst estimates ...

Ecolab's first-quarter earnings and revenue fell slightly but the water-products company reiterated its 2025 operating-earnings projection, anticipating that tariff-related surcharges and supply-chain ...

Trade deficits subtract from gross domestic product, the official scorecard of the U.S. economy. The record trade gap in the first quarter is expected to produce a GDP reading of just 0.4% annual ...

France issued 5 billion euros ($5.71 billion) in the syndicated tap of the 3.00% June 2049 green OAT on Tuesday, one of the banks said. Books closed in excess of 74 billion euros, including 3.5 ...

Sherwin-Williams shares rose 3% in premarket trading as key metrics grew within the first quarter despite choppy demand. Shares were trading around $342. The stock is down 0.3% on the year.

Our call of the day from Truist Advisory Services' co-chief investment officer Keith Lerner takes a stab at that. His view is that the S&P 500 has hit a wall, with near-term upside limited to 5%, but ...

S&P Global plans to spin off its automotive-data insights business into a separate public company. The provider of credit ratings and financial intelligence said Monday it aims to separate the company ...

Pfizer said it still expects adjusted 2025 profit of $2.80 a share to $3 a share, while analysts expect full-year earnings of $2.94 a share. Pfizer also projected 2025 revenue of $61 billion to $64 ...